Brookfield Business Partners L.P. LP Units (BBU) Q2 2025 Earnings Call Transcript

Brookfield Business Partners (BBU) reported robust Q2 2025 results, with adjusted EBITDA rising to $591 million, bolstered by strong operational performance and strategic acquisitions. The firm notably executed a highly accretive secondary transaction, selling partial interests in three businesses to a new Brookfield evergreen fund for $690 million in fund units at an 8.6% discount to NAV, which management highlighted as significant given BBU's current 50% trading discount to its intrinsic value. This move, alongside over $800 million in asset realizations and $160 million in year-to-date unit repurchases, underscores BBU's focus on surfacing value and enhancing per-unit returns. The company further emphasized resilient portfolio performance, driven by operational improvements and strategic AI integration for efficiency gains.

Analysis

Brookfield Business Partners reported a strong second quarter, with adjusted EBITDA increasing to $591 million from $524 million in the prior year, supported by underlying operational performance and contributions from recent acquisitions. A key strategic development was the partial sale of interests in three businesses into a Brookfield-managed evergreen fund, generating $690 million in redeemable fund units at an 8.6% discount to Net Asset Value (NAV). Management highlighted this transaction as highly accretive, demonstrating a pathway to surface value near private market valuations, in stark contrast to BBU's public units trading at a discount closer to 50% of their stated NAV. This initiative, combined with over $800 million in total asset realizations, bolsters a pro forma liquidity position of $2.9 billion. Capital allocation priorities remain focused on deleveraging, accretive acquisitions like the planned $145 million investment in First National Financial, and aggressive unit repurchases, with $160 million of a targeted $250 million program completed year-to-date. Operationally, despite some volume softness in certain markets, core holdings like DexKo and Clarios are demonstrating margin expansion—with DexKo's margins up 200 basis points since acquisition—driven by cost management and the systematic integration of AI to enhance efficiency.

Key Decisions for Investors

• Investors should focus on the execution of BBU's strategy to narrow its significant valuation discount to NAV, viewing the recent secondary transaction at a single-digit discount as a key proof point for monetizing assets at values far superior to the public market price.
• Given the commitment to an ongoing $250 million repurchase program and the renewal of the normal course issuer bid, the continued buyback of units at a deep discount to intrinsic value represents a primary and highly accretive driver of per-unit value growth.
• Monitor the operational performance of core portfolio companies, as their demonstrated ability to expand margins through efficiency gains amidst macro uncertainty suggests significant operating leverage and amplified performance in a broader economic recovery.
• While the overall portfolio is resilient, investors should track the progress of assets like Scientific Games over the next year to ensure that strategic initiatives and contract wins translate into the expected earnings growth, which has been slower than originally forecast.